NASDAQ:LMAT - LeMaitre Vascular Stock Price, Forecast & News

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular declared a quarterly dividend on Monday, October 21st. Stockholders of record on Wednesday, November 20th will be paid a dividend of $0.085 per share on Thursday, December 5th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend is Tuesday, November 19th. View LeMaitre Vascular's Dividend History.

LeMaitre Vascular Inc (NASDAQ:LMAT) announced its quarterly earnings data on Wednesday, October, 23rd. The medical instruments supplier reported $0.25 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.21 by $0.04. The medical instruments supplier had revenue of $29.10 million for the quarter, compared to the consensus estimate of $28.15 million. LeMaitre Vascular had a return on equity of 13.38% and a net margin of 16.76%. The firm's revenue for the quarter was up 20.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.21 earnings per share. View LeMaitre Vascular's Earnings History.

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for LeMaitre Vascular.

4 brokers have issued twelve-month price targets for LeMaitre Vascular's stock. Their forecasts range from $37.00 to $40.00. On average, they anticipate LeMaitre Vascular's stock price to reach $39.00 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for LeMaitre Vascular.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LeMaitre Vascular.

Press coverage about LMAT stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. LeMaitre Vascular earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for LeMaitre Vascular.

Some companies that are related to LeMaitre Vascular include Cantel Medical (CMD), Irhythm Technologies (IRTC), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Cardiovascular Systems (CSII), AtriCure (ATRC), Atrion (ATRI), Silk Road Medical (SILK), Shockwave Medical (SWAV), Cryolife (CRY), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX) and Orthofix Medical (OFIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), AbbVie (ABBV), Sociedad Quimica y Minera de Chile (SQM), Gilead Sciences (GILD), NVIDIA (NVDA), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Adobe (ADBE), Boeing (BA) and Teva Pharmaceutical Industries (TEVA).

LeMaitre Vascular's stock is owned by many different of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (8.58%), Summit Creek Advisors LLC (1.61%), Wedge Capital Management L L P NC (0.35%), California Public Employees Retirement System (0.23%), Arizona State Retirement System (0.05%) and Eqis Capital Management Inc. (0.03%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

LMAT stock was sold by a variety of institutional investors in the last quarter, including Arizona State Retirement System, Conestoga Capital Advisors LLC, California Public Employees Retirement System and Louisiana State Employees Retirement System. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

LMAT stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Summit Creek Advisors LLC, Eqis Capital Management Inc., Campbell & CO Investment Adviser LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for LeMaitre Vascular.

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LMAT stock can currently be purchased for approximately $36.75.

LeMaitre Vascular has a market capitalization of $734.67 million and generates $105.57 million in revenue each year. The medical instruments supplier earns $22.94 million in net income (profit) each year or $0.84 on an earnings per share basis. View Additional Information About LeMaitre Vascular.

The official website for LeMaitre Vascular is http://www.lemaitre.com/.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.